DP011 | CLINICAL IMPACT OF UNTARGETED BASELINE PLASMA METABOLOMICS IN NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA

Introduction. Metabolomics is emerging as a promising tool to identify novel prognostic biomarkers in oncohematology. Its prognostic impact in diffuse large B cell lymphoma (DLBCL) is largely unknown. The aim of this study was to investigate the potential clinical impact and biological correlations...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	R. Dondolin, D. Marradi, M. Almasri, E. Barberis, L. Terzi Di Bergamo, C. Cosentino, A. Bruscaggin, M. Salehi, D. Talotta, R. Bruna, G.M. Rivolta, M. Bellia, J. Nabki, B. Al Deeban, L. Cividini, S. Mouhssine, N. Maher, J. Ghanej, F. Maiellaro, A. Andorno, F. Mercalli, E.A. Martino, A. Mokhtar Mahmoud, W. Al Essa, N. Marie Diop, E. Secomandi, C. Deambrogi, S. Rasi, R.L. Boldorini, M. Gentile, G.A. Palumbo, V. Gattei, R. Foà, D. Rossi, G. Gaidano, M. Manfredi, R. Moia
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Ferrata Storti Foundation 2025-09-01
Σειρά:	Haematologica
Διαθέσιμο Online:	https://haematologica.org/article/view/12775
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!